Tetanus toxoid reduced diphtheria toxoid and acellular pertussis vaccine adsorbed (GlaxoSmithKline)

N/A

Report date: 2023/04/27 14:59:55

Base Information

Drug NameTetanus toxoid reduced diphtheria toxoid and acellular pertussis vaccine adsorbed (GlaxoSmithKline)
Drug Alias Name破伤风类毒素，减少的白喉类毒素和非细胞百日咳疫苗吸附（葛兰素史克）dTpa Booster Vaccine (263855)DTaP vaccine adult - GlaxoSmithKlineadsorbed (Boostrix) - GSKRefortrix +[7] 
ClassificationVaccines > Biological material > Toxoid vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsTetanusDiphtheriaMeningococcal Infections +[4] 
Global Approved IndicationsTetanusDiphtheriaWhooping Cough
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2005/05/03
Country/TerritoryBelgiumUnited StatesVietnam +[8] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPending
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline PlcNovartis Pharma AgEmory University
Active IndicationsTetanusDiphtheriaWhooping Cough
Inactive IndicationsMeningococcal Infections

Other Information

ATC CodeJ07CA02
Related LinksN/A